“The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team”, Вопр. онкол., vol. 70, no. 3, pp. 541–549, Jul. 2024, doi: 10.37469/0507-3758-2024-70-3-541-549.